Publications
Export 16 results:
Filters: Author is Bouchard, Roch-Hugo [Clear All Filters]
, “Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics.”, World J Biol Psychiatry, pp. 1-8, 2020.
, “A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia.”, Neuropsychol Rehabil, vol. 26, no. 3, pp. 321-44, 2016.
, “Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder.”, Schizophr Res, vol. 175, no. 1-3, pp. 186-192, 2016.
, “Comorbidity between anxiety disorders and recent-onset psychotic disorders.”, Schizophr Res, vol. 166, no. 1-3, pp. 353-4, 2015.
, “Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.”, Eur Arch Psychiatry Clin Neurosci, vol. 264, no. 4, pp. 333-43, 2014.
, “The role of recollection in source memory: an examination of schizophrenia patients and their first-degree relatives.”, Brain Cogn, vol. 75, no. 2, pp. 147-53, 2011.
, “Schizophrenia patients with polydipsia and water intoxication are characterized by greater severity of psychotic illness and a more frequent history of alcohol abuse.”, Schizophr Res, vol. 118, no. 1-3, pp. 285-91, 2010.
, “Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia.”, Cogn Neuropsychiatry, vol. 14, no. 6, pp. 542-58, 2009.
, “Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.”, Am J Drug Alcohol Abuse, vol. 34, no. 1, pp. 75-82, 2008.
, “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.
, “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.
, “A pilot feasibility study of an extension of the acquaintanceship recruitment procedure in recent-onset psychosis.”, J Nerv Ment Dis, vol. 193, no. 8, pp. 560-3, 2005.
, “Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics.”, J Clin Psychiatry, vol. 65, no. 4, pp. 557-64, 2004.
, “A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translation.”, J Nerv Ment Dis, vol. 192, no. 12, pp. 864-7, 2004.
, “A pilot neuropsychological study of Kraepelinian and non-Kraepelinian schizophrenia.”, Schizophr Res, vol. 62, no. 1-2, pp. 155-63, 2003.
